1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The NSF submission deadline was December 16, 2024 per NSF solicitation 24-607. Applications had to be submitted to NSF, not NIH. Awards were anticipated for summer/fall 2025. The stored grant has no deadline.
Molecular Foundations for Biotechnology (MFB) program is sponsored by U.S. National Science Foundation (NSF) in partnership with National Institutes of Health's National Human Genome Research Institute (NHGRI). This joint program funds research that aims to better understand the untapped capabilities of ribonucleic acid (RNA) for potentially far-reaching biotechnology applications, including cancer-fighting therapies.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NOT-HG-25-017: Notice of NIH Participation in the National Science Foundation Molecular Foundations for Biotechnology (MFB) Partnerships to Transform Emerging Industries Program Notice of NIH Participation in the National Science Foundation Molecular Foundations for Biotechnology (MFB) Partnerships to Transform Emerging Industries Program National Human Genome Research Institute ( NHGRI ) The purpose of this notice is to announce that the NIH is collaborating on the multi-agency funding opportunity, Molecular Foundations for Biotechnology (MFB) Partnerships to Transform Emerging Industries (NSF 24-607).
The National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) will participate in the MFB initiative led by the National Science Foundation (NSF). MFB applications must aim to develop and provide proof-of-concept testing of tools, methodology and/or accelerate fundamental discoveries about RNA structure, interactions, and functions at molecular or genome and transcriptome-wide scales.
The proposed research and outcomes should have significant relevance to physiological conditions. The program will also prioritize projects with potential for biotechnology applications that impact economic sectors such as agriculture or energy production, or help mitigate the effects of climate change, improve environmental sustainability, and/or combat global pandemics, among other societal benefits.
The NHGRI will consider applications that are relevant to the NHGRI mission to accelerate scientific and medical breakthroughs that improve human health. Detailed information about this program can be obtained on the NSF website: https://new. nsf.
gov/funding/opportunities/mfb-molecular-foundations-biotechnology.
NIH Partner Interests: National Human Genome Research Institute NHGRI supports resources, approaches, and technologies that accelerate genomic research focused on the structure and biology of genomes; the genomics of disease; the implementation and effectiveness of genomic medicine; computational genomics and data science; the impact of genomic technology, advances, and implementation on health disparities and health equity; and ethical, legal, and social issues related to genomic advances.
In general, NHGRI supports studies that provide generalizable methods and knowledge. Approaches that are comprehensive across the genome or are generalizable across variants, tissues, diseases, or function may be in scope for NHGRI to the extent they address priority areas described in the NHGRI 2020 Strategic Vision and on the web pages for the research mission of NHGRIs Extramural Divisions and Offices.
Applications for studies relevant only to a particular disease or organ system should be directed to the appropriate Institute or Center. Applications whose primary scientific objective is to understand a single biological or behavioral process, the pathophysiology of a disease, or the mechanism of action of an intervention, will not be in scope for NHGRI.
Application Preparation and Submission Instructions : The deadline for submission of applications to NSF in response to the MFB Program is December 16, 2024. Applications must be submitted to the NSF in accordance with NSF 24-607 and not to the NIH. The scientific review of the MFB applications will be a jointly-conducted initial peer review organized by NSF.
Meritorious applications may be recommended for funding by either NSF or NIH, at the option of the participating agencies. Subsequent to the NSF review, eligible applicants whose research is appropriate for NHGRI and have received highly meritorious scores will be provided with instructions on how to submit their applications in an NIH-approved format directly to the Center for Scientific Review of the NIH for further processing.
Subsequent submission and grant administration procedures will be in accordance with NIH policy. Potential applicants are strongly encouraged to contact NIH or NSF program officials prior to submitting an application. Award Information: It is anticipated that the MFB program will issue approximately five awards in the summer or fall of 2025.
All awards are subject to the availability of funds. The award duration is no more than three years for NSF and NIH awards.
For this solicitation, award sizes must not exceed $1,500,000 in total costs (direct and indirect) for the entire project and a duration and must be commensurate with the scale and scope of the research Please direct all inquiries to: National Human Genome Research Institute (NHGRI) Weekly TOC for this Announcement NIH... Turning Discovery Into Health ®
According to the current listing, eligibility includes: Research teams. Confirm the full requirements in the official notice before applying.
Molecular Foundations for Biotechnology (MFB) program is funded by U.S. National Science Foundation (NSF) in partnership with National Institutes of Health's National Human Genome Research Institute (NHGRI). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start with the full solicitation document linked on this page — it contains the submission instructions and required forms.
MGPV Travel Grant is sponsored by Geological Society of America (GSA), Mineralogy, Geochemistry, Petrology, Volcanology Division. MGPV Travel grants support student travel to the annual GSA meeting. Applications are restricted to active graduate or undergraduate students who are the presenting authors of an accepted abstract at the annual GSA meeting.
Research Opportunities in Space and Earth Science (ROSES) - 2025: A.4 Rapid Response and Novel Research in Earth Science is sponsored by National Aeronautics and Space Administration (NASA) Science Mission Directorate (SMD). This omnibus research funding opportunity includes various program elements, with rolling submissions for Earth Science research through August 2026. Proposers to Earth Science using the NASA Center for Climate Simulation high-end computing facility must include specific budget details.
On August 26, 2026, NSF named the STC class of 2026: TEMPEST at Michigan State, GENIE at Northwestern, and a human-robot co-adaptation center at UT Austin. $90 million total, $6 million a year each. The 2023 class was four centers and $120 million. The award size is intact; the shelf space shrank 25 percent — and that is the number that should reshape how you plan a center proposal.
Read articleNew NIH awards have fallen 34% in 2026, NSF is running months behind, and a proposed OMB rule would let political appointees terminate grants mid-stream. The funding environment for academic research has structurally changed. Here is a clear-eyed diversification strategy for PIs, research offices, and institutions that cannot wait for the political fight to resolve.
Read articleOMB's proposed rewrite of 2 CFR Part 200 would bar political appointees from deferring to peer reviewers and require senior-appointee sign-off on every discretionary grant. NIH new awards are already down about 34% in 2026. Here is what the merit-review changes actually say, how 'Gold Standard Science' becomes a scoring lever, why R1 universities are being written out of some solicitations, and what principal investigators and research offices should do before October 1.
Read article